Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
Recruiting · NCT05384496 · Registry updated 2026-02-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Axitinib and Nivolumab for the Treatment of Mucosal Melanoma | mucosal melanoma | Recruiting | Phase 2 | 2026-02-18 | NCT05384496 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 753 |
| Pfizer | 431 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Memorial Sloan Kettering Westchester | Harrison | United States | 204 |